Mediastinal images resembling thymus following 131-I treatment for thyroid cancer

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 63, Issue 2, 2005, Pages 114-117

  Montella, Liliana ^a   Caraglia, M ^b,c   Abbruzzese, A ^b   Soricelli, A ^d   Caputi, M ^b   Squame, G ^d   Salvatore, M ^d   Del Prete, S ^a   Palmieri, G ^d  

^a SAN GIOVANNI DI DIO HOSPITAL   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

131 I therapy; Thymic hyperplasia; Thyroid cancer; Whole body scan

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131; LEVOTHYROXINE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLICULAR CARCINOMA; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; MEDIASTINUM TUMOR; POSITRON EMISSION TOMOGRAPHY; THYMUS; THYROID CANCER; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; TUMOR DIFFERENTIATION; WHOLE BODY SCINTISCANNING;

EID: 23844471084     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2005.649     Document Type: Article

References (30)

1. McDougall IR. Whole-body scintigraphy with radioiodine-131. A comprehensive list of false positives with some examples. Clin Nucl Med 1995; 20: 869-875.
2. Bakheet SM, Hammami M. Patterns of radioiodine uptake by the lactating breast. Eur J Nucl Med 1994; 21: 604-608.
3. Fernandez-Ulloa M, Maxon HR, Mehta S, Sholton LJ. Iodine-131 uptake by primary lung adenocarcinoma. JAMA 1976; 236: 857-858.
4. Hoschl R, Choy DHL, Gandevia B. Iodine-131 uptake in inflammatory lung disease: a potential pitfall in treatment of thyroid carcinoma. J Nucl Med 1988: 29: 701-706.
5. Ramanna L, Waxman AD, Brachman MB, et al. Correlation of thyroglobulin measurements and radioiodine scans in the follow-up of patients with differentiated thyroid cancer. Cancer 1985; 55: 1525-1529
6. Salvatore M, Gallo A. Accessory thyroid in the anterior mediastinum: case report. J Nucl Med 1975; 16: 1135-1136.
7. Jackson GL, Flicklinger FW, Graham WP III, Kennedy TJ. Thymus accumulation of radioactive iodine. Pennsylvania Medicine 1979; 11: 37-38.
8. Michigishi T, Mizukami Y, Shuke N, et al. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer. Eur J Nucl Med 1993; 20: 75-79.
9. Veronikis IE, Simkin P, Braverman LE. Thymic uptake of iodine-131 in the anterior mediastinum. J Nucl Med 1996; 37: 991-992.
10. Vermiglio F, Baudin E, Travagli JP, et al. Iodine concentration by the thymus in thyroid carcinoma. J Nucl Med 1996; 37: 1830-1831.
11. Salvatori M, Saletnich I, Rufini V, Troncone L. Unusual false-positive radioiodine whole-body scans in patients with differentiated thyroid carcinoma. Clin Nucl Med 1997; 22: 380-383.
12. Wilson LM, Barrington SF, Morrison ID, Kettle AG, O'Doherty MJ, Coakley AJ. Therapeutic implications of thymic uptake of radioiodine in thyroid carcinoma. Eur J Nucl Med 1998; 25: 622-628.
13. Davidson I, McDougall R. How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans? Eur J Nucl Med 2000; 27: 425-30.
14. Hofman P, Battaglione V. Epithelial tumors with thymus differentiation of the thyroid gland and the neck. Arch Anat Cytol Pathol 1998; 46: 141-4.
15. Spitzweg C, Joba W, Eisenmenger W, Heufelder AE. Analysis of human sodium symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 1998; 83: 1746-51.
16. Meller J, Becker W. The human sodium-iodine symporter (NIS) as a key for specific thymic iodine-131 uptake. Eur J Nucl Med 2000; 27: 473-4.
17. Fabris N, Moccheggiani E, Mariotti S, Pacini F, Pinchera A. Thyroid function modulates thymic endocrine activity. J Clin Endocrinol Metab 1986; 62: 474-478.
18. Dardenne M, Savino W, Bach JF. Modulation of thymic endocrine function by thyroid and steroid hormones. Int J Neurosci 1988; 39: 325-34.
19. Fabris N, Moccheggiani E, Mariotti S, Pacini F, Pinchera A. Thyroid-thymus interactions during development and aging. Horm Res 1989; 31: 85-9.
20. Moccheggiani E, Amadio L, Fabris N. Neuroendocrine-thymus interactions. I. In vitro modulation of thymic factor secretion by thyroid hormones. J Endocrinol Invest 1990; 13: 139-147.
21. Goya RG, Brown OA, Bolognani F. The thymus-pituitary axis and its changes during aging. Neuroimmunomodulation 1999; 6: 137-142.
22. Abou-Rabia N, Kendall MD. Involution of the rat thymus in experimentally induced hypothyroidism. Cell Tissue Res 1994; 277: 447-55.
23. Fabris N, Moccheggiani E, Provinciali M. Plasticity of neuro-endocrine-thymus interactions during aging: a minireview. Cell Mol Biol (Noisy-le-grand) 1997; 43: 5209-41.
24. Murakami M, Hosoi Y, Negishi T, et al. Thymic hyperplasia in patients with Graves'disease: identification of thyrotropin receptors in human tissue. J Clin Invest 1996; 98: 2228-34.
25. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 17: 396: 690-5.
26. Flores KG, Li J, Sempowski GD, Haynes BF, Hale LP. Analysis of the human thymic perivascular space during aging. J Clin Invest 1999; 104: 1031-9.
27. Shanker A. Is thymus redundant after adulthood? Immunol Lett 2004; 91: 79-86.
28. Choyke PL, Zeman RK, Gootenberg JE, Greenberg JN, Hoffer F, Frank JA. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. Am J Roentgenol 1987; 149: 269-272.
29. Fahy GM. Apparent induction of partial thymic regeneration in a normal human subject: a case report. J Anti Aging Med 2003; 6: 219-27.
30. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143-9.